Many medications today are tested mainly on white men – putting millions of patients at risk for unknown side-effects. Our expert discusses the dangers of homogenous clinical trials and the current efforts working to improve the science.
Guest Information:
- Dr. Robert A. Winn, Director, Virginia Commonwealth University Massey Cancer Center, President, Association of American Cancer Institutes
Leave a Reply